| Submission to first decision
(The average time from manuscript submission to desk rejection, direct rejection/acceptance or assignment to the first editor) Note: For manuscripts that fully comply with the journal template. However, this timeframe does not apply to manuscripts with formatting or guideline deficiencies. If a manuscript is returned to the authors for corrections, the administrative review process will restart from the re-submission date. |
3 weeks |
|---|---|
| Submission to decision after review (For papers that are sent to review, the average time from submission to receipt of first editor decision) | 6 weeks |
| Submission to final decision (The average time from manuscript submission to the final editorial decision) | 16 weeks |
| Submission to publication (The average time from acceptance to publication. Manuscript published in early view are also included in this calculation) | 24 weeks |
ACTA Pharmaceutica Sciencia
2011 , Vol 53 , Num 2
BIOLOGICAL VALUE OF THE HETEROCYCLIC COMPOUND QUINAZOLINE
Department of Pharmaceutical Chemistry, Swamy Vivekanandha College of Pharmacy, Elayampalayam, Tiruchengode, India
Viewed :
18102
-
Downloaded :
6255
The present review reveals the various biological activities of the heterocyclic compound, indazole including anti-inflammatory, antimicrobial, antitubercular, anticancer, antidepressant, anticonvulsant, antihistaminic, antihypertensive and other activities. From the observed biological activities of the heterocyclic moiety, indazole, we conclude that medicinal properties of quinazolines have to be explored in near future for treatment of various pathological conditions.
Keywords :
QUINAZOLINE, ANTICONVULSANT, ANTIMICROBIAL, ANTICANCER